Bolstering your armamentarium with SGLT2 inhibitors
Novak LM, and Kruger DF. Bolstering your armamentarium with SGLT2 inhibitors. Nurse Pract 2017.
The Nurse practitioner
Sodium-glucose cotransporter-2 inhibitors have a unique mechanism of action in the kidneys that causes glucosuria, which lowers plasma glucose. They are also associated with reduced body weight, BP, and a low incidence of hypoglycemia. The pharmacologic profiles/clinical implications of canagliflozin, dapagliflozin, and empagliflozin are discussed in this article.
ePub ahead of print